NeuroSense Therapeutics
has strong commercial potential in als year | NeuroSense Therapeutics
Deck date
October 2024
Slide
22 of 27
Related slides by other companies
IPO
July 2020
Results
May 2024
Investor Presentation
May 2023
SPAC
June 2021
Other recent decks by NeuroSense Therapeutics
Investor Presentation
January 2024
Investor Presentation
December 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies